Cim Investment Management Inc Intellia Therapeutics, Inc. Transaction History

Cim Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$58.27 - $118.99 $100,282 - $204,781	-1,721 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$100.76 - $138.36 $173,407 - $238,117	1,721 New	1,721 $203,000
Q2 2019 Aug 08, 2019	SELL	$13.88 - $18.41 $299,058 - $396,661	-21,546 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$12.79 - $17.62 $2,340 - $3,224	-183 Reduced 0.84%	21,546 $368,000
Q1 2018 May 10, 2018	BUY	$19.43 - $34.95 $422,194 - $759,428	21,729 New	21,729 $458,000

344

98.4M

784K

713K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $734M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cim Investment Management Inc with notifications on news.